REGULATION OF P27 AND ITS ROLE IN G1 PROGRESSION
REGULATION OF P27 AND ITS ROLE IN G1 PROGRESSION
批准号:
2668499
负责人:
ANDREW KOFF
金额:
$19.42万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-03-01 至 2000-02-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: This is a resubmission of an application to study the CDK
inhibitor p27. p27 was originally identified and characterized by the
PI while a post-doctoral fellow. This grant is based on the analysis
of three models that might explain the normal role of p27. In one
model, p27 levels provide a threshold of inhibitor in G1. To activate
a G1 CDK, the levels of cyclin-CDK complexes must increase above the
threshold of p27 in the cells. In the second model p27 is a scaffold on
which cyclin and CDK polypeptides are assembled. The third model
suggests that different specificities of p27 binding are achieved by
various post-translational modifications. This application proposes to
test various aspects of these models. In the first aim, the PI will test
the properties of the threshold model. The timing of p27 protein and
RNA expression will be studied in synchronized cell populations.
Discrepancies of RNA and protein expression will be followed by
determining the rates of synthesis and degradation of p27. Next, the
regulation of association of p27 with cyclin-CDK complexes will be
determined by analyzing timing of association, relative levels of p27
versus the cyclin-CDK proteins, and changes in post-translational
modification. Then the regulation of p27 associated kinase activity
will be determined. The kinases that account for this activity, the
timing of activity versus assembly, and the range of substrates for p27
will be determined. Using this characterization for comparison, the
second specific aim will analyze how p27 changes in different growth and
differentiation systems. The PI proposes to study differences in
protein synthesis and degradation rates, if p27-associated kinases still
exist in non-proliferating cells, and whether p27 properties change in
direct response to differentiating agents. Next analogous
differentiation and growth arrest procedures will be performed with p27-
null ES cells to determine if p27 is required for these changes. In the
final aim, the PI will analyze cells for proteins that associate with p27
by immunoprecipitation and two-hybrid analysis. Previous work has shown
that p27 can be isolated in a large molecular weight complex. The
characterization of this complex will be done in both proliferating and
differentiating cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CDK4 Inhibitor Therapy: Identification of Biomarkers and Combination Therapies for Liposarcoma
-
批准号:10247698
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2018
-
负责人:ANDREW KOFF
-
依托单位:
CDK4 Inhibitor Therapy: Identification of Biomarkers and Combination Therapies for Liposarcoma
-
批准号:10468963
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2018
-
负责人:ANDREW KOFF
-
依托单位:
CDK4 Inhibitor Therapy: Identification of Biomarkers and Combination Therapies for Liposarcoma
-
批准号:10016097
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2018
-
负责人:ANDREW KOFF
-
依托单位:
CDK inhibitors in tumor progression
-
批准号:7912564
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2009
-
负责人:ANDREW KOFF
-
依托单位:
CDK inhibitors in tumor progression
-
批准号:7637444
-
项目类别:
-
资助金额:$41.48万
-
财政年份:2001
-
负责人:ANDREW KOFF
-
依托单位:
CDK inhibitors in tumor progression
-
批准号:8070471
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2001
-
负责人:ANDREW KOFF
-
依托单位:
P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?
-
批准号:6693775
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2001
-
负责人:ANDREW KOFF
-
依托单位:
P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?
-
批准号:6833487
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2001
-
负责人:ANDREW KOFF
-
依托单位:
CDK inhibitors in tumor progression
-
批准号:7851172
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2001
-
负责人:ANDREW KOFF
-
依托单位:
CDK inhibitors in tumor progression
-
批准号:7303589
-
项目类别:
-
资助金额:$40.62万
-
财政年份:2001
-
负责人:ANDREW KOFF
-
依托单位:
P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?
-
批准号:6233528
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2001
-
负责人:ANDREW KOFF
-
依托单位:
P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?
-
批准号:6626792
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2001
-
负责人:ANDREW KOFF
-
依托单位:
P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?
-
批准号:6489416
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2001
-
负责人:ANDREW KOFF
-
依托单位:
CDK inhibitors in tumor progression
-
批准号:7494098
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2001
-
负责人:ANDREW KOFF
-
依托单位:
REGULATION OF P27 AND ITS ROLE IN G1 PROGRESSION
-
批准号:2883025
-
项目类别:
-
资助金额:$24.34万
-
财政年份:1996
-
负责人:ANDREW KOFF
-
依托单位:
REGULATION OF P27 AND ITS ROLE IN G1 PROGRESSION
-
批准号:6636129
-
项目类别:
-
资助金额:$37.15万
-
财政年份:1996
-
负责人:ANDREW KOFF
-
依托单位:
REGULATION OF P27 AND ITS ROLE IN G1 PROGRESSION
-
批准号:2378294
-
项目类别:
-
资助金额:$22.53万
-
财政年份:1996
-
负责人:ANDREW KOFF
-
依托单位:
REGULATION OF P27 AND ITS ROLE IN G1 PROGRESSION
-
批准号:6519653
-
项目类别:
-
资助金额:$36.07万
-
财政年份:1996
-
负责人:ANDREW KOFF
-
依托单位:
REGULATION OF P27 AND ITS ROLE IN G1 PROGRESSION
-
批准号:6363268
-
项目类别:
-
资助金额:$35.03万
-
财政年份:1996
-
负责人:ANDREW KOFF
-
依托单位:
REGULATION OF P27 AND ITS ROLE IN G1 PROGRESSION
-
批准号:6045557
-
项目类别:
-
资助金额:$31.62万
-
财政年份:1996
-
负责人:ANDREW KOFF
-
依托单位:
海外基金